• OPEN AN ACCOUNT
Indian Indices
Sensex
74,003.82 -777.94
( -1.04%)
Global Indices
Nasdaq
52,442.46 -151.83
(-0.29%)
Dow Jones
7,640.91 -37.07
(-0.48%)
Hang Seng
63,634.18 141.19
(0.22%)
Nikkei 225
10,692.77 42.33
(0.40%)
Forex
USD-INR
95.47 0.03
(0.03%)
EUR-INR
110.72 -0.23
(-0.20%)
GBP-INR
129.12 -0.04
(-0.03%)
JPY-INR
0.62 0.00
(0.29%)

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506879
INE942C01045
79.7351477
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUJTHEM
113.2
5509.97
EPS(TTM)
Face Value()
Div & Yield %
3.74
1
0.13
 

tulive developers ltd
Mangal Credit & Fincorp standalone net profit rises 109.16% in the March 2026 quarter
May 29,2026
Net profit of Mangal Credit & Fincorp rose 109.16% to Rs 5.48 crore in the quarter ended March 2026 as against Rs 2.62 crore during the previous quarter ended March 2025. Sales rose 59.31% to Rs 21.30 crore in the quarter ended March 2026 as against Rs 13.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.14% to Rs 15.31 crore in the year ended March 2026 as against Rs 13.07 crore during the previous year ended March 2025. Sales rose 40.98% to Rs 69.90 crore in the year ended March 2026 as against Rs 49.58 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales21.3013.37 59 69.9049.58 41
OPM %81.3674.05 -77.8176.99 -
PBDT7.904.53 74 22.5419.78 14
PBT7.434.15 79 20.8618.54 13
NP5.482.62 109 15.3113.07 17